Ascletis Pharma Inc. (HKG:1672)

Hong Kong · Delayed Price · Currency is HKD

15.22

-0.27 (-1.74%)

May 20, 2026, 11:25 AM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	2.03M	1.28M	56.60M	54.09M	76.88M
Pharmaceuticals Growth	58.07%	-97.73%	4.63%	-29.64%	119.64%
Total	2.03M	1.28M	56.60M	54.09M	76.88M
Total Growth	58.07%	-97.73%	4.63%	-29.64%	119.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Hong Kong	1.62M	-	-	-	-
Other region	409.00K	1.28M	-	26.00K	5.93M
Other region Growth	-68.12%	-	-	-99.56%	-
Mainland China	-	-	56.60M	54.06M	70.95M
Mainland China Growth	-	-	4.68%	-23.80%	102.71%
Total	2.03M	1.28M	56.60M	54.09M	76.88M
Total Growth	58.07%	-97.73%	4.63%	-29.64%	119.64%

Source: S&P Global Market Intelligence.